Genetic Investigations in Cerebral Palsy
Author Information
Author(s): Anna P. Basu, Karen Low, Thiloka Ratnaike, David Rowitch
Primary Institution: Population Health Sciences Institute, Newcastle University
Hypothesis
What is the role of genetic factors in the diagnosis and treatment of cerebral palsy?
Conclusion
Genomic testing can improve diagnosis and personalized treatment for children with cerebral palsy.
Supporting Evidence
- 11% to 40% of patients diagnosed with cerebral palsy may have monogenic conditions.
- The Wnt pathway is implicated in the pathophysiology of some genetic disorders related to cerebral palsy.
- Genomic testing can lead to personalized medicine approaches for children with cerebral palsy.
- Misdiagnosis of cerebral palsy can occur due to overlapping symptoms with other neurological conditions.
Takeaway
This study looks at how genes can affect children with cerebral palsy and why understanding these genes can help doctors give better care.
Methodology
The review discusses genetic testing methods and their implications for diagnosing cerebral palsy.
Potential Biases
Potential biases in misdiagnosis of cerebral palsy due to overlapping symptoms with other conditions.
Limitations
The study highlights the need for a comprehensive genotype-phenotype reference dataset, which is currently lacking.
Statistical Information
P-Value
p<0.05
Confidence Interval
95% CI 27–45%
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website